It is likely that the levels of TP53I13 expression may vary in tumor and paracancerous groups; hence, we explored this conjecture by analyzing DElncRNAs, DEmRNAs, and DEmiRNAs in glioma samples. This evidence concerns the gene TP53I13 and glioma.